Lorcainide

This classification denotes an antiarrhythmic agent with the molecular formula C22H27ClN2O, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier (SRS UNII) KGJ2T0N7IQ, chemically known as r 15,889 but more generally known as lorcainide, which bears US NIH Compound Identifier 42884. European Medicines Agency schedules Lorcainide in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08584MIG. The term LORCAINIDE is an International Non-Proprietary Name or INN (see World Health Organization INN reference publication, Volume 32, No 10 1978, List 18). World Health Organization schedules lorcainide in its Anatomical Therapeutic Chemical (ATC) Classification. LORCAINIDE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations, for tariff and trade purposes, schedule lorcainide under HS 29333999 and SITC 51574. As of Q4 2014, LORCAINIDE remains US FDA's Preferred Term for this commodity. Lorcainide bears US NLM identifiers UMLS ID C0065183 and NCI Concept Code C83894. SMILES: CLC1CCC(N(C2CCN(CC2)C(C)C)C(=O)CC2CCCCC2)CC1.